Granuloma aséptico facial idiopático

Hiraldo-Gamero, A.; Vera-Casaño, Ángel; Sánz-Trelles, A.

doi:10.1016/j.ad.2012.12.001

Cited by 12 publications

(3 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…La histología objetiva un granuloma inflamatorio en la dermis superficial y profunda, a veces bien delimitado, con linfocitos, histiocitos y neutrófilos, así como células gigantes multinucleadas entremezcladas o en el centro de la lesión [1][2][3]6 . También se han descrito hallazgos de foliculitis granulomatosa 3 .…”

Section: Discussionunclassified

“…Por este motivo, la abstención terapéutica parece consolidarse como una opción adecuada para su manejo 6,8 . No se ha demostrado eficacia de los tratamientos tópicos habituales utilizados para la rosácea, pero en la experiencia de algunos autores el tratamiento por vía oral con metronidazol (20 mg/kg/día al menos 4 semanas) o claritromicina (30 mg/kg/día 2-8 semanas) puede producir mejorías espectaculares [1][2][3]8 .…”

Section: Discussionunclassified

“…Afecta por igual a ambos sexos, con edades comprendidas entre los 8 meses y los 13 años, con una edad media de 4 años 1,2 . Aunque puede alcanzar 2,5 cm de diámetro, su tamaño medio se sitúa en 1 cm [2][3][4][5][6] . La duración del nódulo antes de la primera visita varía de 1 semana a 1 año, con una media de 4 meses 2 .…”

Section: Introductionunclassified

See 2 more Smart Citations

Granuloma aséptico facial idiopático

Centeno¹,

González²,

López³

et al. 2014

Rev Clin Med Fam

View full text Add to dashboard Cite

Section: Discussionunclassified

See 1 more Smart Citation

Granuloma aséptico facial idiopático

Centeno¹,

González²,

López³

et al. 2014

Rev Clin Med Fam

View full text Add to dashboard Cite

Efficacy of treatments for rosacea in the pediatric population: A systematic review

Geng,

Bourkas,

Sibbald

et al. 2023

JEADV Clinical Practice

View full text Add to dashboard Cite

The prevalence of rosacea in the pediatric population is rare and treatment recommendations specific to the pediatric population are lacking. Our objective is to perform a systematic review of the published literature to identify treatments used for rosacea in the pediatric population (age <18 years) and describe their efficacy. Literature searches were performed in four electronic databases: Medline, Embase, CINAHL and EBM Reviews. Data extraction included rosacea subtype, treatment regimen and clinical outcomes. Seventy‐six studies were included, reporting on a total of 389 patients. The most commonly reported treatments included erythromycin, metronidazole, azithromycin, tacrolimus/pimecrolimus and corticosteroids in topical formulations. Isotretinoin and physical treatment modalities were reported to be effective in treating severe recalcitrant cases of rosacea. In our review, we describe the most commonly reported therapies with demonstrated efficacy in treating pediatric rosacea. The evidence supports therapy with topical anti‐inflammatory options initially, with the addition of systemic antibiotics for cases refractory to topical monotherapy.

show abstract